Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategy for Minimize the Risk for Insulin Induced Lipohypertrophy and Its Related Consequences: Innovative Insulin Injection Sites Map

NCT07561086 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT07561086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07561086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategy for Minimize the Risk for Insulin Induced Lipohypertrophy and Its Related Consequences: Innovative Insulin Injection Sites Map
Lead sponsor
Helwan University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2025
Completion date
January 30, 2026
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lipohypertrophy, type 1 diabetes mellitus